Journal Menu► ▼ Journal Menu
Journal Browser► ▼ Journal Browser
Special Issue "Global Trends of COVID-19 Vaccination and Immunology"
A special issue of Vaccines (ISSN 2076-393X). This special issue belongs to the section "COVID-19 Vaccines and Vaccination".
Deadline for manuscript submissions: closed (30 April 2023) | Viewed by 22286
Special Issue Editor
Interests: vaccines; vaccination; immunology; COVID-19
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
In late 2019, a novel coronavirus (SARS-CoV-2) was first identified in Wuhan, China. This marked the beginning of the COVID-19 pandemic, which has placed a stranglehold on healthcare systems worldwide and resulted in over 5 million deaths globally. Rapid and coordinated efforts between industry, government, and academia led to the development and approval of several vaccines using different technologies (e.g., mRNA, adenovirus, recombinant protein) with many other candidates in various stages of clinical development. Irrespective of their availability, uptake of COVID-19 vaccines varies across different regions, and the accessibility and distribution of COVID-19 vaccines remains a critical issue for many parts of the world.
For this Special Issue, we invite the submission of research articles and review articles examining current global trends in COVID-19 vaccination and COVID-19 epidemiology, including (but not limited to) the following themes:
- The impact of COVID-19 vaccination programs on morbidity and mortality, particularly in individuals with comorbidities;
- Challenges for implementing COVID-19 vaccination programs in low-income countries;
- The impact of emerging SARS-CoV-2 variants on vaccine efficacy.
Dr. Stephen N. Crooke
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Vaccines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- vaccine efficacy
- vaccine uptake